Healthcare Industry Leader Jeff Dobro, M.D., Joins Transcarent as Chief Innovation Officer
Mercer’s Former U.S. Clinical Services and Innovation Strategy Leader to drive new consumer-directed platform for employees and risk-sharing for self-insured employers
January 28, 2021
San Francisco, CA, January 28, 2021 – Transcarent, the first comprehensive, consumer-directed health and care platform for employees of self-insured employers, announced today that Dr. Jeff Dobro, M.D., FACR, has joined the company as its new Chief Innovation Officer. Dr. Dobro will lead the company’s product and clinical innovations as Transcarent looks to transform the system of care to empower individuals through their healthcare journey with better information, more choice, and an ability to share in the benefits of their decision.
“Jeff is one of the healthcare industry’s most highly regarded healthcare strategy and physician leaders who brings a high level of expertise in delivering and managing care both for individuals as well as entire populations,” said Krishnan Sridharan, President of Transcarent. “His unique background creating solutions that deliver a better experience and significant value for the individual employee and their families as well as for their employers will be critical as Transcarent continues to expand our product innovation and clinical solutions to the self-insured employer market.”
Prior to joining Transcarent, Dr. Dobro was the U.S. Clinical Services and Innovation Strategy Leader for Mercer, a global benefits consulting leader. He was responsible for Mercer’s clinical consulting team and health strategy development. Dr. Dobro was previously the Chief Medical Officer at One Medical (NYSE: ONEM). Before that, he spent six years as the Chief Medical Officer for RedBrick Health and as a consultant at Willis Towers Watson. His ongoing focus has been on designing innovative value-based and consumer-focused care initiatives for employers, employees and providers. Dr. Dobro is a board-certified internist and rheumatologist and an Associate Professor at NYU School of Medicine. He earned his Doctor of Medicine from Drexel University.
“I am very excited to join the Transcarent team and support our vision to empower each individual to make informed choices about their health and care and enable them to share in the financial value of those decisions,” said Dr. Dobro. “We are offering our Members a trusted, simple, seamless, and high value end-to-end healthcare journey. I’ve spent more than 25 years working to transform the delivery of care in the U.S. and now is the time to bring high-touch high-tech health decision support, and value-based care delivery services together in one integrated platform. Together with our employer partners, we can make significant strides in improving the quality, accessibility, and affordability of healthcare for millions of employees and their families.”
The Transcarent platform combines many of the commonly used healthcare services in one seamless mobile application that provides employees with guidance to better understand their choices in care and the associated costs of that care. Transcarent offers self-insured employers a risk-based model that fully aligns incentives allowing employees to trust that Transcarent will focus on quality first, provide clear and unbiased information and a full range of choices, and share the rewards from better decisions they make.
Transcarent acquired BridgeHealth in October 2020 as part of a $44 million Series A funding round led by 7wireVentures, Alta Partners, and General Catalyst. BridgeHealth is the leader in Center of Excellence and Appropriate Site of Care musculoskeletal surgical solutions for some of the nation’s largest and most innovative self-insured employers. BridgeHealth serves over 1 million Members with more than 150 Centers of Excellence and Ambulatory Surgery Centers, more than 300 pre-negotiated surgical bundles across eight surgical categories, and provides documented improvements in quality of care, resulting in 80% lower complications.
Transcarent, a Silicon Valley-based consumer digital health company, is creating the first consumer-directed health and care platform. Using a combination of software, technology, health guides, and data science, Transcarent empowers consumers with the kind of information, guidance and access that leads to better care, better outcomes, and more cost-effective decisions for everyone. We believe that having the right information, tools, and incentives in the decision-making process can positively transform the way we all experience our care.